Results 41 to 50 of about 39,210 (233)

Predictors of target lesion revascularization after paclitaxel-coated balloon angioplasty for de novo coronary artery lesions

open access: yesFrontiers in Cardiovascular Medicine
BackgroundEvidence is limited on factors driving target lesion revascularization (TLR) after drug-coated balloon (DCB) treatment for de novo coronary lesions.
Tommy Suharjo   +3 more
doaj   +1 more source

Long-term clinical safety and efficacy of drug-eluting stents in real-world patients [PDF]

open access: yes, 2011
Since the fi rst balloon angioplasty was performed in the late 1970’s, percutaneous coronary intervention (PCI) has undergone rapid transformation to become an essential treatment option for coronary artery disease as an alternative to surgery.
Kukreja, N. (Neville)
core   +1 more source

Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation [PDF]

open access: yes, 2002
Background. Experimental studies have shown an activation of the angiotensin-converting enzyme (ACE) system as a response to endothelial injury. Recent publications have elucidated the hypothesis that the ACE gene polymorphism may influence the level of ...
de Jaegere, Peter   +10 more
core   +1 more source

Coronary arterial aneurysm formation after balloon angioplasty

open access: yesThe American Journal of Cardiology, 1983
The mechanism of coronary stenosis dilatation by percutaneous transluminal coronary angioplasty (PTCA) is incompletely understood. Five men who developed coronary arterial aneurysms at the site of PTCA are described. All patients were in New York Heart Association functional class III or IV at the time of PTCA. In 2 patients acute myocardial infarction
From The University of Florida, Division of Cardiovascular Medicine, Regional Veterans Administration Medical Center, Gainesville, Florida USA ( host institution )   +5 more
openaire   +3 more sources

Deployable 3D‐Printed Vascular Stent with Surface‐Catalysed Endogenous Nitric Oxide Generation

open access: yesAdvanced Materials, EarlyView.
A deployable 3D‐printed vascular stent was fabricated with surface‐catalyzed endogenous nitric oxide generation, representing a promising new direction for stent development. The stent can be remotely controlled by magnetic force in its compressed state and fully deployed at the target site using an untethered heat source, potentially eliminating the ...
Kun Zhou   +8 more
wiley   +1 more source

Balloon Angioplasty - The Legacy of Andreas Grüntzig, M.D. (1939-1985)

open access: yesFrontiers in Cardiovascular Medicine, 2014
In 1974, at the Medical Policlinic of the University of Zürich, German-born physician-scientist Andreas Grüntzig (1939-1985) successfully applied a balloon-tipped catheter to re-open a severely stenosed femoral artery, a procedure which he initially ...
Matthias eBarton, MD, FAHA   +3 more
doaj   +1 more source

Lotus root‐like appearance in the left anterior descending artery treated with a drug‐coated balloon angioplasty

open access: yesClinical Case Reports, 2022
A lotus root‐like appearance of the coronary artery diagnosed by optical coherence tomography (OCT) is characterized by old coronary thrombi that form small lumen channels.
Wataru Takagi   +4 more
doaj   +1 more source

Adjunctive strategies in the management of resistant, 'undilatable' coronary lesions after successfully crossing a CTO with a guidewire. [PDF]

open access: yes, 2014
Successful revascularisation of chronic total occlusions (CTOs) remains one of the greatest challenges in the era of contemporary percutaneous coronary intervention (PCI).
Fairley, SL   +5 more
core   +1 more source

Bioabsorbable Endovascular Adhesive Tape (BEAT) for Improving Vascular Regeneration

open access: yesAdvanced Science, EarlyView.
A bioabsorbable endovascular adhesive tape (BEAT) platform based on a hierarchical polyelectrolyte complex is developed to enhance drug delivery in the DCB system. The coating enables rapid transfer to the vessel, provides short‐term mechanical support, and promotes both immediate transfer and long‐term retention of drugs at the lesion site.
Jiarong Wang   +13 more
wiley   +1 more source

Ischemia Modified Albumin levels in patients with Stable Angina Pectoris who underwent Percutaneous Coronary Intervention

open access: yesMajalah Kardiologi Indonesia, 2007
Background. Ischemia Modified Albumin (IMA) is a biomarker of myocardial ischemia. Blood levels of IMA rise in patients who develop ischemia during percutaneous coronary intervention (PCI).
Hariadi Hariawan   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy